Jul. 15 at 2:12 AM
$COCH The Company just continues to produce strong data from its Acclaim study (below) while developing its global IP on a first-in-world technology for
$3.0B total addressable market,
$50M valuation. Take advantage of the stock price consolidating
$0.60-0.80 (IMO) over the intermediate term with multiplier upside possible (ultimately) on successful completion of Acclaim.
https://www.stocktitan.net/news/COCH/envoy-medical-reports-positive-12-month-data-showing-continued-zbqg4tfskyd2.html